{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:27:05Z","timestamp":1762100825217},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.2119\/2007-00133.ramalho","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T15:48:40Z","timestamp":1210952920000},"page":"309-317","source":"Crossref","is-referenced-by-count":27,"title":["Apoptosis in Transgenic Mice Expressing the P301L Mutated Form of Human Tau"],"prefix":"10.1186","volume":"14","author":[{"given":"Rita M.","family":"Ramalho","sequence":"first","affiliation":[]},{"given":"Ricardo J. S.","family":"Viana","sequence":"additional","affiliation":[]},{"given":"Rui E.","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Clifford J.","family":"Steer","sequence":"additional","affiliation":[]},{"given":"Walter C.","family":"Low","sequence":"additional","affiliation":[]},{"given":"Cec\u00edlia M. P.","family":"Rodrigues","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,3,27]]},"reference":[{"key":"1405309_CR1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ. (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol. Rev. 81:741\u201366.","journal-title":"Physiol. Rev."},{"key":"1405309_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0962-8924(98)01368-3","volume":"8","author":"EM Mandelkow","year":"1998","unstructured":"Mandelkow EM, Mandelkow E. (1998) Tau in Alzheimer\u2019s disease. Trends Cell. Biol. 8:425\u20137.","journal-title":"Trends Cell. Biol."},{"key":"1405309_CR3","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1073\/pnas.121119298","volume":"98","author":"A Alonso","year":"2001","unstructured":"Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments. Proc. Natl. Acad. Sci. U. S. A. 98:6923\u20138.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1405309_CR4","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1021\/bi0272510","volume":"42","author":"TC Gamblin","year":"2003","unstructured":"Gamblin TC, Berry RW, Binder LI. (2003) Tau polymerization: role of the amino terminus. Biochemistry. 42:2252\u20137.","journal-title":"Biochemistry"},{"key":"1405309_CR5","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1097\/00001756-199412000-00031","volume":"5","author":"JH Su","year":"1994","unstructured":"Su JH, Anderson AJ, Cummings BJ, Cotman CW. (1994) Immunohistochemical evidence for apoptosis in Alzheimer\u2019s disease. Neuroreport. 5:2529\u201333.","journal-title":"Neuroreport"},{"key":"1405309_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/00005072-199909000-00012","volume":"58","author":"LA Selznick","year":"1999","unstructured":"Selznick LA et al. (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58:1020\u20136.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1405309_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1172\/JCI200420640","volume":"114","author":"RA Rissman","year":"2004","unstructured":"Rissman RA et al. (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114:121\u201330.","journal-title":"J. Clin. Invest."},{"key":"1405309_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00401-005-1027-3","volume":"110","author":"J Newman","year":"2005","unstructured":"Newman J et al. (2005) Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. Acta Neuropathol. (Berl.) 110:135\u201344.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"1405309_CR9","doi-asserted-by":"publisher","first-page":"10032","DOI":"10.1073\/pnas.1630428100","volume":"100","author":"TC Gamblin","year":"2003","unstructured":"Gamblin TC et al. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. U. S. A. 100:10032\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1405309_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K et al. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science. 309:476\u201381.","journal-title":"Science"},{"key":"1405309_CR11","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","volume":"25","author":"M Ramsden","year":"2005","unstructured":"Ramsden M et al. (2005) Age-dependent neurofib-rillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 25:10637\u201347.","journal-title":"J. Neurosci."},{"key":"1405309_CR12","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2353\/ajpath.2006.050840","volume":"168","author":"TL Spires","year":"2006","unstructured":"Spires TL et al. (2006) Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 168:1598\u2013607.","journal-title":"Am. J. Pathol."},{"key":"1405309_CR13","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1046\/j.1471-4159.2000.0752368.x","volume":"75","author":"CMP Rodrigues","year":"2000","unstructured":"Rodrigues CMP et al. (2000) Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. J. Neurochem. 75:2368\u201379.","journal-title":"J. Neurochem."},{"key":"1405309_CR14","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1172\/JCI1325","volume":"101","author":"CMP Rodrigues","year":"1998","unstructured":"Rodrigues CMP, Fan G, Ma X, Kren BT, Steer CJ. (1998) A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101:2790\u20139.","journal-title":"J. Clin. Invest."},{"key":"1405309_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2119\/2003-00042.Rodrigues","volume":"9","author":"S Sol\u00e1","year":"2003","unstructured":"Sol\u00e1 S, Castro RE, Laires PA, Steer CJ, Rodrigues CMP. (2003) Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. Mol. Med. 9:226\u201334.","journal-title":"Mol. Med."},{"key":"1405309_CR16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1471-4159.2006.04007.x","volume":"98","author":"RM Ramalho","year":"2006","unstructured":"Ramalho RM et al. (2006) Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer\u2019s disease mutant neuroblastoma cells. J. Neurochem. 98:1610\u20138.","journal-title":"J. Neurochem."},{"key":"1405309_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1471-4159.2004.02517.x","volume":"90","author":"RM Ramalho","year":"2004","unstructured":"Ramalho RM et al. (2004) Inhibition of the E2F-1\/p53\/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells. J. Neurochem. 90:567\u201375.","journal-title":"J. Neurochem."},{"key":"1405309_CR18","doi-asserted-by":"publisher","first-page":"10671","DOI":"10.1073\/pnas.162362299","volume":"99","author":"CD Keene","year":"2002","unstructured":"Keene CD et al. (2002) Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington\u2019s disease. Proc. Natl. Acad. Sci. U. S. A. 99:10671\u20136.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1405309_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00004647-200204000-00010","volume":"22","author":"CMP Rodrigues","year":"2002","unstructured":"Rodrigues CMP et al. (2002) Neuroprotection by a bile acid in an acute stroke model in the rat. J. Cereb. Blood Flow Metab. 22:463\u201371.","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1405309_CR20","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1073\/pnas.1031632100","volume":"100","author":"CMP Rodrigues","year":"2003","unstructured":"Rodrigues CMP et al. (2003) Tauroursodeoxy-cholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc. Natl. Acad. Sci. U. S. A. 100:6087\u201392.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1405309_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3727\/096020198389960","volume":"11","author":"WM Duan","year":"2002","unstructured":"Duan WM, Rodrigues CMP, Zhao LR, Steer CJ, Low WC. (2002) Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson\u2019s disease. Cell Transplant. 11:195\u2013205.","journal-title":"Cell Transplant."},{"key":"1405309_CR22","doi-asserted-by":"publisher","first-page":"42655","DOI":"10.1074\/jbc.M505910200","volume":"280","author":"R Ved","year":"2005","unstructured":"Ved R et al. (2005) Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J. Biol. Chem. 280:42655\u201368.","journal-title":"J. Biol. Chem."},{"key":"1405309_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jnr.490350513","volume":"35","author":"GJ Brewer","year":"1993","unstructured":"Brewer GJ, Torricelli JR, Evege EK, Price PJ. (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:567\u201376.","journal-title":"J. Neurosci. Res."},{"key":"1405309_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.). 82:239\u201359.","journal-title":"Acta Neuropathol. (Berl.)."},{"key":"1405309_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM. (2001) Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science. 293:1491\u20135.","journal-title":"Science"},{"key":"1405309_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2796.2005.01570.x","volume":"258","author":"B Fadeel","year":"2005","unstructured":"Fadeel B, Orrenius S. (2005) Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 258:479\u2013517.","journal-title":"J. Intern. Med."},{"key":"1405309_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/00005072-199411000-00008","volume":"53","author":"A Migheli","year":"1994","unstructured":"Migheli A, Cavalla P, Marino S, Schiffer D. (1994) A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53:606\u201316.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1405309_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI22317","volume":"114","author":"DW Dickson","year":"2004","unstructured":"Dickson DW. (2004) Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J. Clin. Invest. 114:23\u20137.","journal-title":"J. Clin. Invest."},{"issue":"21","key":"1405309_CR29","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1242\/jcs.113.21.3737","volume":"113","author":"A Abraha","year":"2000","unstructured":"Abraha A et al. (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer\u2019s disease. J. Cell. Sci. 113 Pt 21:3737\u201345.","journal-title":"J. Cell. Sci."},{"key":"1405309_CR30","doi-asserted-by":"publisher","first-page":"8325","DOI":"10.1021\/bi027348m","volume":"42","author":"RW Berry","year":"2003","unstructured":"Berry RW et al. (2003) Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Biochemistry. 42:8325\u201331.","journal-title":"Biochemistry"},{"key":"1405309_CR31","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","volume":"27","author":"Z Berger","year":"2007","unstructured":"Berger Z et al. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27:3650\u201362.","journal-title":"J. Neurosci."},{"key":"1405309_CR32","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1523\/JNEUROSCI.1125-05.2005","volume":"25","author":"SY Park","year":"2005","unstructured":"Park SY, Ferreira A. (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J. Neurosci. 25:5365\u201375.","journal-title":"J. Neurosci."},{"key":"1405309_CR33","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0896-6273(00)80615-7","volume":"21","author":"M Goedert","year":"1998","unstructured":"Goedert M, Crowther RA, Spillantini MG. (1998) Tau mutations cause frontotemporal dementias. Neuron. 21:955\u20138.","journal-title":"Neuron"},{"key":"1405309_CR34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:1487\u201391.","journal-title":"Science"},{"key":"1405309_CR35","first-page":"1711","volume":"94","author":"S Oddo","year":"2007","unstructured":"Oddo S et al. (2007) Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. J. Neurochem. 94:1711\u20138.","journal-title":"J. Neurochem."},{"key":"1405309_CR36","doi-asserted-by":"publisher","first-page":"23802","DOI":"10.1074\/jbc.M500356200","volume":"280","author":"DC David","year":"2005","unstructured":"David DC et al. (2005) Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J. Biol. Chem. 280:23802\u201314.","journal-title":"J. Biol. Chem."},{"key":"1405309_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED et al. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science. 316:750\u20134.","journal-title":"Science"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/2007-00133.Ramalho","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/2007-00133.Ramalho.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T19:49:51Z","timestamp":1631303391000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/2007-00133.Ramalho"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,27]]},"references-count":37,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["1405309"],"URL":"https:\/\/doi.org\/10.2119\/2007-00133.ramalho","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,27]]}}}